CareDx stock climbs after Q3 beats, guidance boost [Seeking Alpha]
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Seeking Alpha
Q3 revenue of $67.2M was well ahead of consensus, but fell 15% compared with $79.4M in the third quarter of 2022. Testing services revenue for the quarter was $47.8M, down 26.2% Y/Y. Adjusted net loss per share of $0.18 also exceeded analysts expectations. Cash burn was better than feared, owing to lower R&D and marketing spend. Adjusted operating expenses for the quarter were $57.7M, down ~$1.2M sequentially from second quarter of 2023. R&D expenses were $19M, down 14.7% Y/Y. CareDx ( CDNA ) maintained a strong balance sheet with cash, cash equivalents and marketable securities of $268.2M and no debt at quarter-end. Buoyed by Q3 results, the company raised its revenue guidance for the full year 2023 to $274M to $278M ( consensus : $255.35M) from previously announced guidance of $240M to $260M. Management noted in the earnings call , "Our goal is to be operating cash flow and adjusted EBITDA positive, and we are pleased to show demonstrable progress on this metric. We have
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) [Seeking Alpha]Seeking Alpha
- CareDx (NASDAQ:CDNA) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CDNA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
- CareDx Provides Notice of Proposed Derivative Settlement [Yahoo! Finance]Yahoo! Finance
- CareDx Provides Notice of Proposed Derivative SettlementBusiness Wire
CDNA
Earnings
- 11/4/25 - Beat
CDNA
Sec Filings
- 12/18/25 - Form 8-K
- 12/15/25 - Form 8-K
- 12/5/25 - Form 4
- CDNA's page on the SEC website